Aidapak Recalls Perphenazine Tablets Due to Potential Labeling Errors
Aidapak Services is recalling Perphenazine 16 mg tablets because they may have been mislabeled as other prescription drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which involves potential adverse health consequences. The hazard involves mislabeling a psychiatric medication as other distinct drugs, which poses a significant risk of incorrect dosing or treatment.
Plain-English summary
Aidapak Services, LLC is recalling Perphenazine 16 mg tablets (NDC 00603506321) due to a labeling error. The recall was initiated because the Perphenazine tablets may have been mislabeled as Melatonin 1 mg, Lithium Carbonate ER 450 mg, or Montelukast Sodium 4 mg chewable tablets.
The affected Perphenazine tablets were distributed in Arizona, California, Oregon, and Washington. The recall covers specific pedigree codes with expiration dates in May and June 2014. The agency has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients and healthcare providers should check their medication labels and contact their pharmacist or physician if they have received Perphenazine tablets that may be mislabeled. Do not take the medication if there is any doubt about the correct identification of the drug.
The recalled product
- Product
- PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603506321.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 2,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- PERPHENAZINE
- Tablet
- 16 mg has the following codes: Pedigree: AD46265_49
- EXP: 5/15/2014
- Pedigree: AD60272_82
- EXP: 5/22/2014
- Pedigree: W002612
- EXP: 6/4/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02